Top of this page
Skip navigation, go straight to the content
#UCB is using next-generation technology to pioneer a completely new approach to #clinicalstudydesign – the End to End Clinical Study Automation program will mean quicker #clinicalstudyresults and faster delivery of new clinical options for patients. http
— UCB News (@ucb_news) 05.03.2021
UCB’s ambition is to transform the lives of people living with severe diseases by developing personalized experiences. We believe that #digitaltransformation will help drive our vision forward. #digitalbusinesstransformation https://t.co/mN05l4nXQC https
— UCB News (@ucb_news) 05.03.2021
Click to visit the #AdvantageHers resource hub to read @CaroWoznaicki top tips for creating a chronic inflammatory disease game plan: https://t.co/kKwruXQRXx https://t.co/HbjffY5ujC
— UCB News (@ucb_news) 04.03.2021
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017